Scarica l'app Stockscreener
7.48
0.54%
0.04
Dopo l'orario di chiusura:
7.50
0.02
+0.27%
Precedente Chiudi:
$7.44
Aprire:
$7.5
Volume 24 ore:
110.59K
Relative Volume:
1.28
Capitalizzazione di mercato:
$224.61M
Reddito:
$8.98M
Utile/perdita netta:
$-31.39M
Rapporto P/E:
-5.5821
EPS:
-1.34
Flusso di cassa netto:
$-24.83M
1 W Prestazione:
+11.64%
1M Prestazione:
+2.19%
6M Prestazione:
-21.26%
1 anno Prestazione:
-9.55%
Intervallo 1D:
$7.3957
$7.75
Intervallo di 1 settimana:
$6.51
$7.75
Portata 52W:
$5.63
$11.42
Profound Medical Corp Stock (PROF) Company Profile
Nome
Profound Medical Corp
Settore
Industria
Telefono
-
Indirizzo
-
Confronta PROF con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
7.48 | 224.61M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-23 | Iniziato | Lake Street | Buy |
| 2024-07-16 | Aggiornamento | Stifel | Hold → Buy |
| 2023-11-28 | Iniziato | Stifel | Hold |
| 2023-08-04 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | Downgrade | Jefferies | Buy → Hold |
| 2020-09-15 | Iniziato | Jefferies | Buy |
Mostra tutto
Profound Medical Corp Borsa (PROF) Ultime notizie
(PRN) Comprehensive Trading Strategy Report (PRN:CA) - Stock Traders Daily
What is Raymond James’ Estimate for TSE:PRN FY2024 Earnings? - Defense World
FY2024 EPS Forecast for Profound Medical Raised by Analyst - Defense World
What is Raymond James’ Estimate for TSE:PRN Q1 Earnings? - Defense World
Brokers Issue Forecasts for PROF Q1 Earnings - Defense World
(PRN) Stock Trading Blueprint (PRN:CA) - Stock Traders Daily
Where are the Opportunities in (PROF) - Stock Traders Daily
How the (PRN) price action is used to our Advantage (PRN:CA) - news.stocktradersdaily.com
Head-To-Head Survey: Autonomix Medical (NASDAQ:AMIX) and Profound Medical (NASDAQ:PROF) - Defense World
Profound Medical (TSE:PRN) Hits New 1-Year LowHere's Why - MarketBeat
(PRN) Equity Trading Insights (PRN:CA) - Stock Traders Daily
Profound Medical to Announce 2024 Financial Results and Host Conference Call - TipRanks
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6Conference Call to Follow - The Manila Times
Profound Medical Earnings Alert: Key Q4 Financial Results Coming March 6What To Watch - StockTitan
(PROF) On The My Stocks Page - Stock Traders Daily
Profound Medical (TSE:PRN) Hits New 12-Month LowWhat's Next? - MarketBeat
Gagnon Advisors LLC Raises Position in Profound Medical Corp. (NASDAQ:PROF) - MarketBeat
Gagnon Securities LLC Raises Holdings in Profound Medical Corp. (NASDAQ:PROF) - MarketBeat
Profound Medical (NASDAQ:PROF) Shares Down 5.3%What's Next? - MarketBeat
Profound Medical (TSE:PRN) Reaches New 1-Year LowHere's Why - MarketBeat
Is beaten down PROF stock a buy now? - Cantech Letter
Interventional Oncology Market to Hit USD 4.24 Billion by 2029 with 9.0% CAGR | MarketsandMarkets - The Malaysian Reserve
Market Sentiment Around Loss-Making Profound Medical Corp. (TSE:PRN) - Simply Wall St
Profound Medical stock hits 52-week low at $6.61 amid market challenges - MSN
GAGNON SECURITIES LLC Acquires Significant Stake in Profound Med - GuruFocus.com
Profound Medical Corp.'s (TSE:PRN) Profit Outlook - Yahoo Finance
Mölnlycke Health Care Appoints New CFO - MPO-mag
(PROF) Long Term Investment Analysis - Stock Traders Daily
Profound Medical Adjusts J.P. Morgan Conference Schedule for Enhanced Visibility - TipRanks
Update: Profound Medical's Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th - The Manila Times
Small caps to watch: Earnings misses, a dividend hike, a CFO departs, and more - The Globe and Mail
Profound Medical Corp. Issues Preliminary Unaudited Revenues Report for Q4 2024 - Defense World
Stocks In Play - Baystreet.ca
Does Profound Medical (PROF) Have the Potential to Rally 100.13% as Wall Street Analysts Expect? - MSN
Onera Health Appoints Maria Sainz as Chair of the Board - Via Ritzau
Stocks In Play: Profound Medical Corp. By Baystreet.ca - Investing.com Canada
Profound Medical Corp (PRN-T) QuotePress Release - The Globe and Mail
Profound Medical Corp. - Baystreet.ca
Profound Medical Corp. Provides Earnings Guidance for the Fourth Quarter and for Full Year of 2024 - Marketscreener.com
Profound Medical reports FY24 revenue above consensus - MSN
Profound Medical Reports Robust Revenue Growth and Transition to U.S. GAAP - TipRanks
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues - The Manila Times
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues - Benzinga
Profound Medical (TSE:PRN) Stock Price Down 2.2%Time to Sell? - MarketBeat
Profound Medical (TSE:PRN) Shares Down 2.2% – Here’s What Happened - Defense World
How the (PROF) price action is used to our Advantage - Stock Traders Daily
Profound Medical to Present at J.P. Morgan Healthcare Conference - TipRanks
Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Key factors to consider when considering risk and progression of BPH - Urology Times
Profound Medical (TSE:PRN) soars 14% this week, taking one-year gains to 18% - Simply Wall St
Profound Medical stock reaffirmed at Buy at Lake Street on favourable setup in 2025 - Investing.com Canada
Profound Medical Corp Azioni (PROF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.16%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):